1. Home
  2. ERAS vs EPRT Comparison

ERAS vs EPRT Comparison

Compare ERAS & EPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$9.95

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Essential Properties Realty Trust Inc.

EPRT

Essential Properties Realty Trust Inc.

HOLD

Current Price

$31.14

Market Cap

6.6B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERAS
EPRT
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.6B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
ERAS
EPRT
Price
$9.95
$31.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
12
Target Price
$14.25
$36.79
AVG Volume (30 Days)
9.1M
2.0M
Earning Date
05-08-2026
04-22-2026
Dividend Yield
N/A
3.98%
EPS Growth
36.23
11.30
EPS
N/A
0.28
Revenue
N/A
$561,219,000.00
Revenue This Year
N/A
$17.12
Revenue Next Year
N/A
$16.27
P/E Ratio
N/A
$110.54
Revenue Growth
N/A
24.82
52 Week Low
$1.06
$28.95
52 Week High
$24.28
$34.73

Technical Indicators

Market Signals
Indicator
ERAS
EPRT
Relative Strength Index (RSI) 33.19 41.91
Support Level $2.07 $29.30
Resistance Level $17.17 $31.71
Average True Range (ATR) 1.74 0.65
MACD -1.29 -0.11
Stochastic Oscillator 8.02 9.38

Price Performance

Historical Comparison
ERAS
EPRT

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

Share on Social Networks: